SCHEMBL10367186

SCHEMBL10367186

CC(=O)C1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18731092 1.00
SCHEMBL5771317 0.93
SCHEMBL2321562 0.93
SCHEMBL890174 0.93
Bromide SCHEMBL6143081 0.91
Hydrochloric Acid SCHEMBL6147870 0.91
Bromide SCHEMBL6143076 0.91
SCHEMBL17928477 0.85
SCHEMBL11367676 0.80 NOS2 (0.44)
SCHEMBL2253501 0.80 NOS2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303526-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-09-28 US disclosed
WO-2022167445-A1 GPR84 ANTAGONISTS AND USES THEREOF Liminal Biosciences Limited (GB) 2022-08-11 WO disclosed
EP-3609883-B1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2022-06-29 EP disclosed
US-11242335-B2 Fluorine-substituted indazole compounds and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-02-08 US disclosed
US-20210101882-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-04-08 US disclosed
EP-3609883-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2020-02-19 EP disclosed
WO-2018188590-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-10-18 WO disclosed
US-20170298001-A1 TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF CORSAIR PHARMA INC (US) 2017-10-19 US disclosed
US-9770439-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-26 US disclosed
US-9701616-B2 Treprostinil derivatives and compositions and uses thereof Corsair Pharma, Inc. (US) 2017-07-11 US disclosed
US-20160199355-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL MAYERS SQUIBB COMPANY (US) 2016-07-14 US disclosed
US-20160158200-A1 Combinations of Hepatitis C Virus Inhibitors BRISTOL MYERS SQUIBB CO (US) 2016-06-09 US disclosed
US-9326973-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-05-03 US disclosed
US-20150297568-A1 Hepatitis C Virus Inhibitors BRISTOL MYERS SQUIBB CO (US) 2015-10-22 US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 US disclosed
EP-2913323-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR Daito Chemix Corporation (JP) 2015-09-02 EP disclosed
US-20150023913-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2015-01-22 US disclosed
US-20130183269-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-07-18 US disclosed
EP-0174567-B1 TETRAHYDROPYRAN-2-YL-ALKENYLTRIAZOLES, FUNGICIDES CONTAINING THEM, PROCESS FOR THE PREPARATION OF THE TRIAZOLE COMPOUNDS AND INTERMEDIATES FOR THE PREPARATION BASF Aktiengesellschaft (DE) 1990-03-21 EP disclosed
EP-0174567-A2 Tetrahydropyran-2-yl-alkenyltriazoles, fungicides containing them, process for the preparation of the triazole compounds and intermediates for the preparation BASF Aktiengesellschaft (DE) 1986-03-19 EP disclosed